
Indian pharma turns to home remedy as tariff malady looms
Companies focusing on the Indian pharmaceutical market are likely to offer a hedge against the ongoing tariff woes even though the fate of the broader sector remains uncertain, according to analysts. Shares of India-focused Mankind Pharma Ltd, Alkem …